PT  - JOURNAL ARTICLE
AU  - Conti, Sara
AU  - Ferrara, Pietro
AU  - Mazzaglia, Giampiero
AU  - D’Orso, Marco I.
AU  - Ciampichini, Roberta
AU  - Fornari, Carla
AU  - Madotto, Fabiana
AU  - Magoni, Michele
AU  - Sampietro, Giuseppe
AU  - Silenzi, Andrea
AU  - Sileo, Claudio V.
AU  - Zucchi, Alberto
AU  - Cesana, Giancarlo
AU  - Manzoli, Lamberto
AU  - Mantovani, Lorenzo G.
TI  - Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy
AID  - 10.1101/2020.07.10.20150565
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.10.20150565
4099  - http://medrxiv.org/content/early/2020/07/11/2020.07.10.20150565.short
4100  - http://medrxiv.org/content/early/2020/07/11/2020.07.10.20150565.full
AB  - Background The real impact of SARS-CoV-2 on overall mortality remains uncertain and surveillance reports attributed to COVID-19 a limited amount of deaths during the outbreak. Aim of this study is to assess the excess mortality (EM) during COVID-19 outbreak in highly impacted areas of northern Italy.Methods We analyzed data on deaths occurred in the first four months of 2020 in health protection agencies (HPA) of Bergamo and Brescia (Lombardy), building a time-series of daily number of deaths and predicting the daily standardized mortality ratio (SMR) and cumulative number of excess deaths (ED) through a Poisson generalized additive model of the observed counts in 2020, using 2019 data as a reference.Results We estimated 5740 (95% Credible Set (CS): 5552–5936) ED in the HPA of Bergamo and 3703 (95% CS: 3535 – 3877) in Brescia, corresponding to 2.55 (95% CS: 2.50–2.61) and 1.93 (95% CS: 1.89–1.98) folds increase in the number of deaths. The ED wave started a few days later in Brescia, but the daily estimated SMR peaked at the end of March in both HPAs, roughly two weeks after the introduction of lock-down measures, with significantly higher estimates in Bergamo (9.4, 95% CI: 9.1–9.7).Conclusion EM was significantly larger than that officially attributed to COVID-19, disclosing its hidden burden likely due to indirect effects on health system. Time-series analyses highlighted the impact of lockdown restrictions, with a lower EM in the HPA where there was a smaller delay between the epidemic outbreak and their enforcement.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNA